Advisor Resource Council United Therapeutics Corp Transaction History

Advisor Resource Council

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 25, 2023	BUY	$212.99 - $276.17 $475,819 - $616,963	2,234 Added 172.78%	3,527 $789,000
Q4 2022 Jan 20, 2023	SELL	$205.95 - $280.43 $53,135 - $72,350	-258 Reduced 16.63%	1,293 $0
Q3 2022 Oct 26, 2022	BUY	$203.3 - $244.17 $315,318 - $378,707	1,551 New	1,551 $325,000
Q4 2021 Feb 11, 2022	SELL	$184.32 - $216.08 $409,559 - $480,129	-2,222 Closed	0 $0
Q3 2021 Nov 16, 2021	BUY	$179.86 - $214.88 $394,792 - $471,661	2,195 Added 8129.63%	2,222 $410,000
Q2 2021 Aug 13, 2021	BUY	$170.47 - $211.93 $4,602 - $5,722	27 New	27 $4,000

676

42.1M

194K

295K

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $16.3B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

Get notified when there are updates to the investment portfolio of Advisor Resource Council, based on Form 13F filings with the SEC.

Stay updated on Advisor Resource Council with notifications on news.